Cormorant Asset Management, LP - 31 Mar 2025 SCHEDULE 13G/A Report for VYNE Therapeutics Inc. Common Stock, par value $0.0001 per share (VYNE)

Filing Manager: Cormorant Asset Management, LP
Reporting Manager: Cormorant Asset Management, LP
Security: VYNE Therapeutics Inc. Common Stock, par value $0.0001 per share
Symbol: VYNE
Shares outstanding: 18,514,414 shares
Disclosed Ownership: 1,849,590 shares
Ownership: 10%
Form type: SCHEDULE 13G/A
Filing time: 19 May 2025, 17:47:42 UTC
Date of event: 31 Mar 2025
Next filing: 14 Aug 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Cormorant Asset Management, LP	10%	1,849,590	0	1,849,590	By: /s/ Bihua Chen	Bihua Chen, Managing Member
Bihua Chen	10%	1,849,590	0	1,849,590	/s/ Bihua Chen	Bihua Chen